Announcements

  • All
  • Announcements 2009
  • Announcements 2010
  • Announcements 2011
  • Announcements 2012
  • Announcements 2017
  • Announcements 2018
  • Announcements 2019
  • Announcements 2020
  • Announcements 2021
  • Announcements 2022
  • Announcements 2024

ANNOUNCEMENT Peania, January 24th, 2020 - Lavipharm S.A., as per L.3340/2005 and the 3/347/12.07.2005 resolution of the Hellenic Capital Market Commission, announces that as of January 20th  2020, Mrs. Eleana Nikolopoulou, attorney at law LL.M University of Munich, assumes the responsibility of Head of Legal.   ...

ANNOUNCEMENT Peania, January 16th, 2020 - Lavipharm S.A. announces that the Board of Directors, in its meeting held on January 16th, 2020, accepted Mr. Telemaque Lavidas’ resignation. It was also decided not to replace the resigned board member as per the corporate by-laws stipulated in Article...

 Peania, December 13th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to its Executive Chairman, Mr. Athanasios Lavidas,...

10.22.19 Announcement  Peania, October 22nd, 2019 - Following recent press posts referring to Mr. Telemaque Lavidas, a member of the Board of Directors of Lavipharm SA, regarding a case being investigated by the US Authorities, Lavipharm S.A. informs that the case has no relation to the...

 Peania, November 29th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm S.A.'s Executive Chairman, Mr. Athanasios...

Peania, November 13th2019 Η Lavipharm S.A. announces that as of today, November 13th 2019, Mr. Panagiotis Giannouleas, an experienced executive in the pharmaceutical market, assumes the responsibilities of Chief Operating Officer (COO) and Country Manager. ...

Lavipharm S.A. announces that, as of September 6th  2019, Mr. Antonis Vogiatzis, who held the position of General Manager, is no longer with the company....

  Peania, December 6th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on December 3rd, 2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's...

  Peania, October 24th 2018 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr. Athanasios...

  Peania, June 29th 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 28.06.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....